Publication number: 20220204478
Abstract: The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), Formula (II), or Formula (III), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Type:
Application
Filed:
May 12, 2020
Publication date:
June 30, 2022
Inventors:
Nadiya Sydorenko, Md Rauful Alam, Lukiana Amedzo, Michael A. Arnold, Suresh Babu, Anuradha Bhattacharyya, Gary Mitchell Karp, Nathaniel T. Kenton, Tom Tuan Luong, Anthony R. Mazzotti, Young-Choon Moon, Christie Morrill, Nicholas Walter Mszar, Jana Narasimhan, Jigar S. Patel, Hongyu Ren, Anthony Turpoff, Gang Wang, Matthew G. Woll, Nanjing Zhang, Xiaoyan Zhang